BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10207054)

  • 1. Ubiquitination and degradation of ATF2 are dimerization dependent.
    Fuchs SY; Ronai Z
    Mol Cell Biol; 1999 May; 19(5):3289-98. PubMed ID: 10207054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors.
    Fuchs SY; Xie B; Adler V; Fried VA; Davis RJ; Ronai Z
    J Biol Chem; 1997 Dec; 272(51):32163-8. PubMed ID: 9405416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
    Steinmüller L; Thiel G
    Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
    Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
    J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation.
    Fuchs SY; Tappin I; Ronai Z
    J Biol Chem; 2000 Apr; 275(17):12560-4. PubMed ID: 10777545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor ATF2 cooperates with v-Jun to promote growth factor-independent proliferation in vitro and tumor formation in vivo.
    Huguier S; Baguet J; Perez S; van Dam H; Castellazzi M
    Mol Cell Biol; 1998 Dec; 18(12):7020-9. PubMed ID: 9819389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells.
    Firestein R; Feuerstein N
    J Biol Chem; 1998 Mar; 273(10):5892-902. PubMed ID: 9488727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors.
    Al Sarraj J; Vinson C; Han J; Thiel G
    J Cell Biochem; 2005 Dec; 96(5):1003-20. PubMed ID: 16149046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.
    Choi CY; Choi BH; Park GT; Rho HM
    J Biol Chem; 1997 Jul; 272(27):16934-9. PubMed ID: 9202004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells.
    Novotny V; Prieschl EE; Csonga R; Fabjani G; Baumruker T
    Nucleic Acids Res; 1998 Dec; 26(23):5480-5. PubMed ID: 9826775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
    Hayakawa J; Depatie C; Ohmichi M; Mercola D
    J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.
    Ramirez-Carrozzi V; Kerppola T
    Mol Cell Biol; 2003 Mar; 23(5):1737-49. PubMed ID: 12588992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic region.
    Haas NB; Cantwell CA; Johnson PF; Burch JB
    Mol Cell Biol; 1995 Apr; 15(4):1923-32. PubMed ID: 7891686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK.
    Sevilla A; Santos CR; Vega FM; Lazo PA
    J Biol Chem; 2004 Jun; 279(26):27458-65. PubMed ID: 15105425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small.
    Bailey J; Europe-Finner GN
    J Mol Endocrinol; 2005 Feb; 34(1):19-35. PubMed ID: 15691875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.
    Falvo JV; Parekh BS; Lin CH; Fraenkel E; Maniatis T
    Mol Cell Biol; 2000 Jul; 20(13):4814-25. PubMed ID: 10848607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
    Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
    Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
    Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
    Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.